Breast Suite
AI-powered, end-to-end breast imaging screening and diagnostic workflow applications, seamlessly integrated into your IT
An AI-powered, end-to-end suite of modular, interoperable applications that are designed to seamlessly integrate into existing breast cancer diagnostic workflows and technology, significantly improving diagnostic accuracy, workflow efficiency and standardization of care.
Book a demo
Explore the industry’s most comprehensive integrated portfolio of AI-powered suites of solutions at the European Congress of Radiology.
Enhanced efficiency and accuracy in breast cancer detection
Enables more accurate diagnosis1,2 with the use of priors3 and automatic localization of regions of interest and degree of suspicion
Provides consistent, automated density classification with a patient-centric, accurate density assessment of 2D or 3D mammograms to support objective diagnostic decisions.
Identifies high risk of developing breast cancer in 1-2 years, based only on a mammogram calibration, with up to x2.4 more accurate than traditional risk models6,7
Automated ultrasound image analysis and lesion detection and characterization according to ACR BI-RADS guidelines.
AI-powered workflow optimization for consistent, efficient diagnosis
Intelligent prioritization
Improves turnaround time by indicating cases based on suspicion level and rapidly flagging high-suspicion exams within minutes, reducing delays and enabling timely same-day follow-up.
AI-powered Safeguard review workflow
Improves cancer detection rate with second reviewer workflow, decreasing false negatives and emphasizing likely missed cancers, including hard-to-detect ones. 2, 7, 8
Quality Analytics
Enables quality monitoring at scale, makes compliance and audit easier and seamless, and supports improvement in mammography quality.
Intelligent reporting
Standardizes and streamlines documentation through auto populated reporting and generation of complete, standardized ultrasound worksheets.
Real World Impact
Improve cancer detection rates with second reviewer workflow
DM (2D)
DBT (3D)
Breast Suite
Clinical impact at scale
Delivered with superior accuracy, driven by our algorithm trained on vast clinical data 6, 7
Explore Clinical Evidence21%
increased cancer detection rate (CDR)1
23%
more cancers detected in women with dense breasts1
20%
more cancers detected in Black/African American women1
Specialist level care
achieved by a group of general radiologists¹¹
Real voices.
Real impact.
Jason R. Sinner M.D.
Medical Director, RadNet/BRMG
“It has made me considerably more efficient due to decreased lag between loading patient studies, in particular as it relates to breast tomography where I can instantly review the current study along with multiple prior exams.”
Dr. Jacqueline Holt
Medical Director, Women’s Imaging, Delaware Imaging Network, RadNet
“Breast Suite applications help me read smarter and more efficiently. It allows me to sort and prioritize mammograms most likely to have cancer in them and draws my attention to what really matters in each image.”
Could Healthcare Begin Before Illness Ever Shows Up?
Rather than waiting for patients to experience symptoms, what if care started with prevention, early detection, and access to critical diagnostic tools?
Finding and treating diseases, like cancer, at earlier stages increases survival rates.3 Screening healthy people helps make early detection more possible. By expanding screening for a range of diseases, more people have the change to stay healthy longer- and this shift has the potential to significantly transform population health.
Discover Population Health Solutions[2] FDA 510(k) clearance K251873. Clinical Performance Testing.
[3] Pending 510k clearance
[4] CE marked for the EU market. Not yet cleared for use in the US.
[5] Breast Ultrasound is pending FDA 510(k) Clearance. Not available in all markets.
[6] Eriksson et al. “A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care.” Science Translational Medicine. May 2022.
[7] Eriksson et al. "Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.” Radiology. Sep 2020.
[8] Rapid image processing flags highly suspicion cases in under 5 minutes when integrated with GE HealthCare’s Senographe Pristina system and using 1 GB bandwidth transmission, and under 15 minutes with HOLOGIC
[9] Louis et al. "National Deployment of AI-driven Workflow has Equitable Impact in Breast Cancer Screening in Diverse and Increased Risk Populations.” Nature Health. 2025.
[10] Louis et al. "Large-scale deployment of a multistage AI-driven workflow increases detection of deadlier breast cancers.” RSNA Chicago. 2025.
[11] McCabe et al. “Multistage AI-Driven Workflow Improves General Radiologist Screening Mammography Performance to the Level of Fellowship-Trained Breast Imagers: Real-world Evidence in >500,000 Patients.” RSNA Chicago. 2025.
[12] Lee et al. National Performance Benchmarks for Screening Digital Breast Tomosynthesis: Update from the Breast Cancer Surveillance Consortium. Apr 11 2023
https://doi.org/10.1148/radiol.222499
Disclaimers: Breast Suite comprises multiple applications including ProFound Pro, Breast Density, Safeguard Review, Risk Assessment, BAC and DeepHealth Viewer, Mammography Insights and Breast Ultrasound. DeepHealth Viewer is manufactured by eRAD, Inc. and distributed byDeepHealth, Inc. Mammography Insigths is manufactured by Aquila, Inc. and distributed by DeepHealth, Inc. Breast Ultrasound is manufactured by See-Mode, Inc. and distributed by DeepHealth, Inc. Any claims made about Breast Suite may reference claims associated with its individual components. Not all products and functionalities are commercially available in all countries.